CTOs on the Move

medi pro inc

www.medi-pro.com

 
medi pro inc is a Houston, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million
  • www.medi-pro.com
  • 11261 Richmond Ave Ste 101
    Houston, TX USA 77082
  • Phone: 281.493.9551

Executives

Name Title Contact Details

Similar Companies

Nucleus Medical Art Inc

Nucleus Medical Art Inc is a Kennesaw, GA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

empire cardiac monitoring

empire cardiac monitoring is a Hewlett, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DCI International

DCI International is a Newberg, OR-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Balt

Since it was established in 1977, Balt has worked with interventional physicians to develop devices to treat complex life-threatening neurovascular conditions such as ischemic strokes, aneurysms, and arteriovenous malformations. A pioneer in the neurovascular field, Balt designs, manufactures, and distributes the broadest portfolio of products in the neurovascular space and is focused on expanding its geographic reach.

Motif Neurotech

Motif Neurotech is a clinical-stage company leading the development of minimally invasive neuromodulation therapeutics for mental health. The company`s lead product, for treatment resistant depression (TRD), is a miniature implant that is designed to treat TRD by increasing activity in the prefrontal cortex. Studies over 20 years show stimulation of the pre-frontal cortex effectively treats treatment resistant depression without the side effects of anti-depressants. However, existing brain stimulation treatments like transcranial magnetic stimulation (TMS) can be expensive and challenging for patients to access, with daily treatments required for six weeks that may need to be repeated. Human and large animal studies show Motif`s prototype stimulates target brain areas like TMS, and the company is preparing to begin clinical trials of their first chronic implants in 2025. Motif`s implant is enabled by patent-pending wireless magnetoelectric power transfer developed at Rice University. Motif`s founders and key team members are clinical, medical device and academic experts with over 5,000 surgical procedures and decades of medical device experience.